Highlights • COVID-19 carries higher risk of myocarditis compared to either mRNA vaccine. • Longer vaccine dosing interval is associated with lower myocarditis risk. • Risk of COVID-19 hospitalization is higher than post vaccination myocarditis risk.
All Keywords
【저자키워드】 COVID-19, mRNA-1273, BNT162b2, myocarditis, Pericarditis, dosing interval,
【저자키워드】 COVID-19, mRNA-1273, BNT162b2, myocarditis, Pericarditis, dosing interval,